NeuBase Therapeutics, Inc. Shareholders' Equity
NeuBase Therapeutics, Inc. had Shareholders' Equity of $9.14 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-11-09
- 2023-09-30: Stockholders' Equity Attributable to Parent $9.14M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $11.25M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $14.45M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $18.22M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-09-30 | $9.14M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $11.25M 10-Q · filed 2023-11-09 | |
| 2023-03-31 | $14.45M 10-Q · filed 2023-11-09 | |
| 2022-12-31 | $18.22M 10-Q · filed 2023-11-09 | |
| 2022-09-30 | $23.19M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $30.31M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $38.16M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $47.13M 10-Q · filed 2023-11-09 | |
| 2021-09-30 | $54.07M 10-QT · filed 2023-06-05 | |
| 2021-06-30 | $60.28M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $23.94M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $28.52M 10-Q · filed 2022-08-11 | |
| 2020-09-30 | $31.29M 10-K · filed 2022-12-21 | |
| 2020-06-30 | $34.68M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $3.99M 10-Q · filed 2021-08-13 | |
| 2019-12-31 | $7.03M 10-Q · filed 2021-05-14 | |
| 2019-09-30 | $10.03M 10-K · filed 2021-12-23 | |
| 2019-06-30 | -$2.38M 10-Q · filed 2020-08-13 | $7.94M 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$1.17M 10-Q · filed 2020-08-13 | $9.01M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$392.50K 10-Q · filed 2020-05-14 | $10.08M 10-Q · filed 2019-02-14 |
| 2018-09-30 | -$41.90K 10-K · filed 2020-12-23 | $10.90M 10-K · filed 2019-01-03 |
| 2018-06-30 | $17.18M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $17.66M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | $19.68M 10-Q · filed 2019-08-14 | |
| 2017-09-30 | $22.84M 10-Q · filed 2019-08-14 | |
| 2017-06-30 | $27.97M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $18.62M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $25.84M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $24.96M 10-K · filed 2019-01-03 | |
| 2016-06-30 | $29.02M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $35.58M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $38.87M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $42.49M 10-K · filed 2017-12-15 | |
| 2015-06-30 | $45.59M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $48.16M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $22.61M 10-Q · filed 2015-02-10 | |
| 2014-09-30 | $26.75M 10-K · filed 2016-12-22 | |
| 2014-06-30 | $28.79M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $3.33M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $4.34M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $5.26M 10-K · filed 2016-12-22 | |
| 2013-06-30 | $6.61M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $2.28M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $540.23K 10-Q · filed 2013-02-19 | |
| 2012-09-30 | $2.43M 10-K · filed 2015-12-14 | |
| 2012-06-30 | $177.03K 10-Q · filed 2012-08-07 | |
| 2012-03-31 | -$693.97K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$3.45M 10-Q/A · filed 2012-02-14 | |
| 2011-09-30 | -$4.78M 10-K · filed 2014-12-22 | |
| 2011-06-30 | -$3.53M 10-Q · filed 2011-08-15 | |
| 2010-09-30 | -$382.46K 10-K · filed 2013-12-27 | |
| 2009-09-30 | $612.68K 10-K · filed 2013-12-27 | |
| 2008-09-30 | $33.20K 10-K · filed 2013-12-27 | |
| 2007-09-30 | -$263.12K 10-K · filed 2013-12-27 | |
| 2006-09-30 | -$683.55K 10-K/A · filed 2012-01-18 |